BMP-7 as antagonist of organ fibrosis

Frontiers in Bioscience

Volumn 14, Issue 13, 2009, Pages 4992-5012

  Weiskirchen, Ralf ^a   Meurer, Steffen K ^a   Gressner, Olav A ^a   Herrmann, Jens ^a   Borkham Kamphorst, Erawan ^a   Gressner, Axel M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Bone morphogenetic protein; CCN proteins; Epithelial to mesenchymal transition; Fibrosis; Intracellular signaling; Review; Therapy; Transforming growth factor beta

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; FIBROSIS; GENETICS; HUMAN; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; FIBROSIS; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 69149109088     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3583     Document Type: Article

References (153)

1. E. Özkaynak, D. C. Rueger, E. A. Drier, C. Corbett, R. J. Ridge, T. K. Sampath, and H. Oppermann: OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 9, 2085-2093(1990)
2. A. T. Dudley, K. M. Lyons, and E. J. Robertson: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9, 2795-2807(1995)
3. G. Luo, C. Hofmann, A. L. Bronckers, M. Sohocki, A. Bradley, and G. Karsenty: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9, 2808-2820(1995)
4. M. Zeisberg, G. A. Müller, and R. Kalluri: Are there endogenous molecules that protect kidneys from injury? The case for bone morphogenic protein-7 (BMP-7). Nephrol Dial Transplant. 19, 759-761(2004) (Pubitemid 38455640)
5. H. Sugimoto, C. Yang, V. S. LeBleu, M. A. Soubasakos, M. Giraldo, M. Zeisberg, and R. Kalluri: BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J 21, 256-264(2007) (Pubitemid 46052564)
6. S. Vukicevic, V. Basic, D. Rogic, N. Basic, M. S. Shih, A. Shepard, D. Jin, B. Dattatreyamurty, W. Jones, H. Dorai, S. Ryan, D. Griffiths, J. Maliakal, M. Jelic, M. Pastorcic, A. Stavljenic, and T. K. Sampath: Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102, 202-214(1998) (Pubitemid 28323847)
7. Y. Shi, and J. Massagué: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700(2003) (Pubitemid 36724933)
8. J. M. Wozney, V. Rosen, A. J. Celeste, L. M. Mitsock, M. J. Whitters, R. W. Kriz, R. M. Hewick, and E. A. Wang: Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534(1988) (Pubitemid 19023695)
9. M. Pecina, M. Haspl, M. Jelic, and S. Vukicevic: Repair of a resistant tibial non-union with a recombinant bone morphogenetic protein-7 (rh-BMP-7). Int Orthop 27, 320-321(2003) (Pubitemid 37362657)
10. M. Zeisberg, C. Yang, M. Martino, M. B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri: Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282, 23337-23347(2007) (Pubitemid 47311952)
11. S. J. Newfeld, R. G. Wisotzkey, and S. Kumar: Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers. Genetics 152, 783-795(1999) (Pubitemid 29272728)
12. R. J. Wordinger, and A. F. Clark: Bone morphogenetic proteins and their receptors in the eye. Exp Biol Med 232, 979-992(2007) (Pubitemid 47358182)
13. P. ten Dijke, O. Korchynskyi, G. Valdimarsdottir, and M. J. Goumans: Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 211, 105-113(2003) (Pubitemid 37491242)
14. W. Sebald, J. Nickel, J. L. Zhang, and T. D. Mueller: Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem 385, 697-710(2004) (Pubitemid 39255628)
15. D. Chen, M. Zhao, and G. R. Mundy: Bone morphogenetic proteins. Growth Factors 22, 233-241(2004) (Pubitemid 40136452)
16. S. Mazerbourg, C. Klein, J. Roh, N. Kaivo-Oja, D. G. Mottershead, O. Korchynskyi, O. Ritvos, and A. J. Hsueh: Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol 18, 653-665(2004) (Pubitemid 38328209)
17. L. David, C. Mallet, S. Mazerbourg, J. J. Feige, and S. Bailly: Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109, 1953-161(2007)
18. M. Scharpfenecker, M. van Dinther, Z. Liu, R. L. van Bezooijen, Q. Zhao, L. Pukac, C. W. Löwik, and P. ten Dijke: BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120, 964-972(2007) (Pubitemid 46638511)
19. K. Miyazono, K. Kusanagi, and H. Inoue: Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 187, 265-276(2001)
20. S. P. Oh, T. Seki, K. A. Goss, T. Imamura, Y. Yi, P. K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim, and E. Li: Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97, 2626-2631(2000) (Pubitemid 30159221)
21. M. J. Goumans, G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke: Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21, 1743-1753(2002) (Pubitemid 34614630)
22. M. J. Goumans, G. Valdimarsdottir, S. Itoh, F. Lebrin, J. Larsson, C. Mummery, S. Karlsson, and P. ten Dijke: Activin receptor-like kinase (ALK) 1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12, 817-828(2003) (Pubitemid 37352776)
23. H. G. König, D. Kögel, A. Rami, and J. H. Prehn: TGF-beta1 activates two distinct type I receptors in neurons: implications for neuronal NF-kappaB signaling. J Cell Biol 168, 1077-1086(2005)
24. O. Scherner, S. K. Meurer, L. Tihaa, A. M. Gressner, and R. Weiskirchen: Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling. J Biol Chem 282, 13934-13943(2007) (Pubitemid 47100463)
25. L. Li, X. Y. Zhao, and B. E. Wang: Down-regulation of transforming growth factor beta 1/activin receptor-like kinase 1 pathway gene expression by herbal compound 861 is related to deactivation of LX-2 cells. World J Gastroenterol 14, 2894-2899(2008)
26. P. Franzén, C. H. Heldin, and K. Miyazono: The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction. Biochem Biophys Res Commun 207, 682-689(1995)
27. R. Wieser, J. L. Wrana, and J. Massagué: GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J 14, 2199-2208(1995)
28. D. Onichtchouk, Y. G. Chen, R. Dosch, Y. Gawantka, H. Delius, J. Massagué, and C. Niehrs: Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401, 480-485(1999) (Pubitemid 29470206)
29. I. Kalajzic, A. Staal, W. P. Yang, Y. Wu, S. E. Johnson, J. H. Feyen, W. Krueger, P. Maye, F. Yu, Y. Zhao, L. Kuo, R. R. Gupta, L. E. Achenie, H. W. Wang, D. G. Shin, and D. W. Rowe: Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem 280, 24618-24626(2005) (Pubitemid 40934550)
30. L. M. Camus, and L. A. Lambert: Molecular evolution of hemojuvelin and the repulsive guidance molecule family. J Mol Evol 65, 68-81(2007) (Pubitemid 47221223)
31. P. J. Halbrooks, R. Ding, J. M. Wozney, and G. Bain: Role of RGM coreceptors in bone morphogenetic protein signaling. J Mol Signal 2:4(2007)
32. J. L. Babitt, F. W. Huang, D. M. Wrighting, Y. Xia, Y. Sidis, T. A. Samad, J. A. Campagna, R. T. Chung, A. L. Schneyer, C. J. Woolf, N. C. Andrews, and H. Y. Lin: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38, 531-539(2006)
33. Y. Xia, J. L. Babitt, Y. Sidis, R. T. Chung, and H. Y. Lin: Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 111, 5195-5204(2008)
34. K. C. Kirkbride, T. A. Townsend, M. W. Bruinsma, J. V. Barnett, and G. C. Blobe: Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 283, 7628-7637(2008)
35. A. Gougos, and M. Letarte: Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265, 8361-8364(1990)
36. P. Lastres, T. Bellon, C. Cabañas, F. Sanchez-Madrid, A. Acevedo, A. Gougos, M. Letarte, and C. Bernabeu: Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J Immunol 22, 393-397(1992)
37. S. K. Meurer, L. Tihaa, B. Lahme, A. M. Gressner, and R. Weiskirchen: Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling. J Biol Chem 280, 3078-3087(2005) (Pubitemid 40189418)
38. N. P. Barbara, J. L. Wrana, and M. Letarte: Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 274, 584-594(1999)
39. E. Gazzerro, and E. Canalis: Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7, 51-65(2006) (Pubitemid 46044349)
40. J. Massagué, J. Seoane, and D. Wotton: Smad transcription factors. Genes Dev 19, 2783-2810(2005) (Pubitemid 41739965)
41. R. S. Lo, Y. G. Chen, Y. Shi, N. P. Pavletich, and J. Massagué: The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. EMBO J 17, 996-1005(1998) (Pubitemid 28077654)
42. U. Persson, H. Izumi, S. Souchelnytskyi, S. Itoh, S. Grimsby, U. Engström, C. H. Heldin, F. Funa, and P. ten Dijke: The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation. FEBS Lett 434, 83-87(1998) (Pubitemid 28404667)
43. Y. G. Chen, and J. Massagué: Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J Biol Chem 274, 3672-3677(1999) (Pubitemid 29077212)
44. A. Nohe, S. Hassel, M. Ehrlich, F. Neubauer, W. Sebald, Y. I. Henis, and P. Knaus: The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277, 5330-5338(2002) (Pubitemid 34968578)
45. Y. Yamaguchi, S. Nagai, J. Ninomiya-Tsuji, M. Nishita, K. Tamai, K. Irie, N. Ueno, E. Nishida, H. Shibuya, and K. Matsumoto: XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 18, 179-187(1999) (Pubitemid 29005034)
46. K. A. Brown, J. A. Pietenpol, and H. L. Moses: A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 101, 9-33(2007) (Pubitemid 46652569)
47. H. Aoki, M. Fujii, T. Imamura, K. Yagi, K. Takehara, M. Kato, and K. Miyazono: Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 114, 1483-1489(2001) (Pubitemid 32427835)
48. G. Mitu, and R. Hirschberg: Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front Biosci 13, 4726-4739(2008) (Pubitemid 351589193)
49. A. Lux, L. Attisano, and D. A. Marchuk: Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 274, 9984-9992(1999)
50. M. Kretzschmar, J. Doody, and J. Massagué: Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389, 618-622(1997) (Pubitemid 27446181)
51. Q. Meng, A. Lux, A. Holloschi, J. Li, J. M. Hughes, T. Foerg, J. E. McCarthy, A. M. Heagerty, P. Kioschis, M. Hafner, and J. M. Garland: Identification of Tctex2beta, a novel dynein light chain family member that interacts with different transforming growth factor-beta receptors. J Biol Chem 281, 37069-37080(2006) (Pubitemid 46042177)
52. V. C. Foletta, M. A. Lim, J. Soosairajah, A. P. Kelly, E. G. Stanley, M. Shannon, W. He, S. Das, J. Massague, and O. Bernard: Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol 162, 1089-1098(2003) (Pubitemid 37174191)
53. R. D. Machado, N. Rudarakanchana, C. Atkinson, J. A. Flanagan, R. Harrison, N. W. Morrell, and R. C. Trembath: Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Hum Mol Genet 12, 3277-3286(2003) (Pubitemid 37541073)
54. Y. Shi, Y. F. Wang, L. Jayaraman, H. Yang, J. Massagué, and N. P. Pavletich: Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell 94, 585-594(1998) (Pubitemid 28427577)
55. K. Miyazono, S. Maeda, and T. Imamura: BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16, 251-263(2005) (Pubitemid 40910315)
56. K. S. Lee, H. J. Kim, Q. L. Li, X. Z. Chi, C. Ueta, T. Komori, J. M. Wozney, E. G. Kim, J. Y. Choi, H. M. Ryoo, and S. C. Bae: Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20, 8783-8792(2000) (Pubitemid 32245911)
57. M. H. Lee, Y. J. Kim, W. J. Yoon, J. I. Kim, B. G. Kim, Y. S. Hwang, J. M. Wozney, X. Z. Chi, S. C. Bae, K. Y. Choi, J. Y. Cho, J. Y. Choi, and H. M. Ryoo: Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280, 35579-35587(2005) (Pubitemid 41532750)
58. S. K. Zaidi, A. J. Sullivan, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J. B. Lian: Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci U S A 99, 8048-8053(2002) (Pubitemid 34651003)
59. K. L. Pearson, T. Hunter, and R. Janknecht R: Activation of Smad1-mediated transcription by p300/CBP. Biochim Biophys Acta 1489, 354-364(1999)
60. Y. Yoshida, S. Tanaka, H. Umemori, O. Minowa, M. Usui, N. Ikematsu, E. Hosoda, T. Imamura, J. Kuno, T. Yamashita, K. Miyazono, M. Noda, T. Noda, and T. Yamamoto: Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103, 1085-1097(2000) (Pubitemid 32037395)
61. S. Akiyoshi, H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono, and M. Kawabata: c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem 274, 35269-35277(1999) (Pubitemid 129509586)
62. W. Wang, F. V. Mariani, R. M. Harland, and K. Luo: Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. Proc Natl Acad Sci U S A 97, 14394-14399(2000) (Pubitemid 32016586)
63. M. Takeda, M. Mizuide, M. Oka, T. Watabe, H. Inoue, H. Suzuki, T. Fujita, T. Imamura, K. Miyazono, and K. Miyazawa: Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. Mol Biol Cell 15, 963-972(2004) (Pubitemid 38316207)
64. A. F. Candia, T. Watabe, S. H. Hawley, D. Onichtchouk, Y. Zhang, R. Derynck, C. Niehrs, and K. W. Cho: Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development 124, 4467-4480(1997) (Pubitemid 27519243)
65. A. Hata, J. Seoane, G. Lagna, E. Montalvo, A. Hemmati-Brivanlou, and J. Massagué J: OAZ uses distinct DNA-and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229-240(2000) (Pubitemid 30064911)
66. K. A. Henningfeld, S. Rastegar, G. Adler, and W. Knöchel: Smad1 and Smad4 are components of the bone morphogenetic protein-4 (BMP-4)-induced transcription complex of the Xvent-2B promoter. J Biol Chem 275, 21827-21835(2000) (Pubitemid 30621751)
67. R. Benezra, R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub: The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59(1990)
68. M. B. Ruzinova, and R. Benezra: Id proteins in development, cell cycle and cancer. Trends Cell Biol 13, 410-418(2003) (Pubitemid 36897645)
69. T. López-Rovira, E. Chalaux, J. Massagué, J. L. Rosa, and F. Ventura: Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J Biol Chem 277, 3176-3185(2002) (Pubitemid 34953179)
70. T. Katagiri, M. Imada, T. Yanai, T. Suda, N. Takahashi, and R. Kamijo: Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7, 949-960(2002)
71. O. Korchynskyi, and P. ten Dijke: Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277, 4883-4891(2002) (Pubitemid 34968524)
72. K. A. Henningfeld, H. Friedle, S. Rastegar, and W. Knöchel: Autoregulation of Xvent-2B; direct interaction and functional cooperation of Xvent-2 and Smad1. J Biol Chem 277, 2097-2103(2002) (Pubitemid 34968793)
73. A. von Bubnoff, D. A. Peiffer, I. L. Blitz, T. Hayata, S. Ogata, Q. Zeng, M. Trunnell, and K. W. Cho: Phylogenetic footprinting and genome scanning identify vertebrate BMP response elements and new target genes. Dev Biol 281, 210-226(2005) (Pubitemid 40719148)
74. T. Ogata, J. M. Wozney, R. Benezra, and M. Noda: Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci U S A 90, 9219-9222(1993) (Pubitemid 23306484)
75. T. Katagiri, A. Yamaguchi, M. Komaki, E. Abe, N. Takahashi, T. Ikeda, V. Rosen, J. M. Wozney, A. Fujisawa-Sehara, and T. Suda: Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127, 1755-1766(1994) (Pubitemid 24380911)
76. A. Hollnagel, V. Oehlmann, J. Heymer, U. Rüther, and A. Nordheim: Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274, 19838-19845(1999)
77. T. Imamura, M. Takase, A. Nishihara, E. Oeda, J. Hanai, M. Kawabata, and K. Miyazono: Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389, 622-626(1997) (Pubitemid 27446182)
78. A. Hata, G. Lagna, J. Massagué, and A. Hemmati-Brivanlou: Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12, 186-197(1998) (Pubitemid 28060449)
79. W. Ishida, T. Hamamoto, K. Kusanagi, K. Yagi, M. Kawabata, K. Takehara, T. K. Sampath, M. Kato, and K. Miyazono: Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 275, 6075-6079(2000) (Pubitemid 30129890)
80. Y. X. Wang, L. X. Qian, D. Liu, L. L. Yao, Q. Jiang, Z. Yu, Y. H. Gui, T. P. Zhong, and H. Y. Song: Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 74, 290-303(2007) (Pubitemid 46533836)
81. B. L. Thériault, T. G. Shepherd, M. L. Mujoomdar, and M. W. Nachtigal: BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28, 1153-1162(2007) (Pubitemid 47062673)
82. R. Kalluri, and E. G. Neilson: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112, 1776-1784(2003) (Pubitemid 38063698)
83. H. Hayashi, S. Abdollah, Y. Qiu, J. Cai, Y. Y. Xu, B. W. Grinnell, M. A. Richardson, J. N. Topper, M. A. Gimbrone, J. L. Wrana, and D. Falb: The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165-1173(1997) (Pubitemid 127678749)
84. A. Nakao, M. Afrakhte, A. Morén, T. Nakayama, J. L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N. E. Heldin, C. H. Heldin, and P. ten Dijke: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 631-635(1997) (Pubitemid 27446184)
85. C. H. Heldin, K. Miyazono, and P. ten Dijke: TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471(1997) (Pubitemid 28013118)
86. S. Itoh, and P. ten Dijke: Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 19, 176-184(2007) (Pubitemid 46386411)
87. G. Murakami, T. Watabe, K. Takaoka, K. Miyazono, and T. Imamura: Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14, 2809-2817(2003) (Pubitemid 36871523)
88. G. M. di Guglielmo, C. le Roy, A. F. Goodfellow, and J. L. Wrana: Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5, 410-421(2003) (Pubitemid 36592263)
89. H. Zhu, P. Kavsak, S. Abdollah, J. L. Wrana, and G. H. Thomsen. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693(1999)
90. H. B. Chen, J. Shen, Y. T. Ip, and L. Xu: Identification of phosphatases for Smad in the BMP/DPP pathway. Genes Dev 20, 648-653(2006)
91. G. Sapkota, C. Alarcón, F. M. Spagnoli, A. H. Brivanlou, and J. Massagué: Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25, 441-454(2007) (Pubitemid 46199289)
92. M. Kretzschmar, F. Liu, A. Hata, J. Doody, and J. Massagué: The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11, 984-995(1997) (Pubitemid 27199878)
93. G. Karsenty, G. Luo, C. Hofmann, and A. Bradley: BMP 7 is required for nephrogenesis, eye development, and skeletal patterning. Ann N y Acad Sci. 785, 98-107(1996) (Pubitemid 26302108)
94. Y. Miyazaki, H. Ueda, T. Yokoo, Y. Utsunomiya, T. Kawamura, T. Matsusaka, I. Ichikawa, and T. Hosoya: Inhibition of endogenous BMP in the glomerulus leads to mesangial matrix expansion. Biochem Biophys Res Commun 340, 681-688(2006) (Pubitemid 43021800)
95. K. A. Hruska, G. Guo, M. Wozniak, D. Martin, S. Miller, H. Liapis, K. Loveday, S. Klahr, T. K. Sampath and J. Morrissey: Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 280, F130-F143 (2000) (Pubitemid 30619554)
96. R. J. Lund, M. R. Davies, and K. A. Hruska: Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease. Curr Opin Nephrol Hypertens 11, 31-36(2002) (Pubitemid 34053335)
97. J. Morrissey, K. Hruska, G. Guo, S. Wang, Q. Chen and S. Klahr: Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13, S14-S21 (2002) (Pubitemid 34008173)
98. S. Wang, and R. Hirschberg: BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 284, F1006-F1013 (2003) (Pubitemid 36443585)
99. M. Zeisberg, C. Bottiglio, N. Kumar, Y. Maeshima, F. Strutz, G. A. Müller and R. Kalluri: Bone morphogenetic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285, F1060-F1067 (2003) (Pubitemid 37421041)
100. H. Sugimoto, G. Grahovac, M. Zeisberg and R. Kalluri: Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenetic protein-7 and advanced glycation end product inhibitors. Diabetes 56, 1825-1833(2007) (Pubitemid 47025452)
101. S. Wang, M. de Caestecker, J. Kopp, G. Mitu, J. LaPage and R. Hirschberg: Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17, 2504-2512(2006) (Pubitemid 44300966)
102. S. Wang, Q. Chen, T. C. Simon, F. Strebeck, L. Chaudhary, J. Morrissey, H. Liapis, S. Klahr and K. A. Hruska: Bone morphogenetic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63, 2037-2049(2003) (Pubitemid 36605815)
103. M. Zeisberg, J. Hanai, H. H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz, and R. Kalluri: BMP-7 counteracts TGF-beta1-induced epithelial-to- mesenchymal transition and reverses chronic renal injury. Nat Med 9, 964-968(2003) (Pubitemid 36889942)
104. K. Kinoshita, Y. Iimuro, K. Otogawa, S. Saika, Y. Inagaki, Y. Nakajima, N. Kawada, J. Fujimoto, S. L. Friedman and K. Ikeda: Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 56, 706-714(2007) (Pubitemid 46662939)
105. M. Zeisberg, C. Yang, M. Martino, M. B. Duncan, F. Rieder, H. Tanjore and R. Kalluri: Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282, 23337-23347(2007) (Pubitemid 47311952)
106. E. M. Zeisberg, O. Tarnavski, M. Zeisberg, A. L. Dorfman, J. R. McMullen, E. Gustafsson, A. Chandraker, X. Yuan, W. T. Pu, A. B. Roberts, E. G. Neilson, M. H. Sayegh, S. Izumo and R. Kalluri: Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13, 952-961(2007) (Pubitemid 47222040)
107. M. Myllärniemi, P. Lindholm, M. J. Ryynänen, C. R. Kliment, K. Salmenkivi, J. Keski-Oja, V. L. Kinnula, T. D. Oury, and K. Koli: Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Am J Respir Crit Care Med 177, 321-329(2008) (Pubitemid 351198376)
108. S. Saika, K. Ikeda, O. Yamanaka, K. C. Flanders, Y. Ohnishi, Y. Nakajima, Y. Muragaki, and A. Ooshima: Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-tomesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 290, C282-C289 (2005)
109. N. Izumi, S. Mizuguchi, Y. Inagaki, S. Saika, N. Kawada, Y. Nakajima, K. Inoue, S. Suchiro, S. L. Friedman, and K. Ikeda: BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. Am J Physiol Lung Cell Mol Physiol 290, L120-L126 (2006)
110. P. J. Miettinen, R. Ebner, A. R. Lopez, and R. Derynck: TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127, 2021-2036(1994)
111. J. M. Fan, Y. Y. Ng, P. A. Hill, D. J. Nikolic-Paterson, W. Mu, R. C. Atkins, and H. Y. Lan: Transforming growth factorbeta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56, 1455-1467(1999) (Pubitemid 29451252)
112. A. M. Hales, M. W. Schulz, C. G. Chamberlain, and J. W. McAvoy: TGF-beta 1 induces lens cells to accumulate alphasmooth muscle actin, a marker for subcapsular cataracts. Curr Eye Res 13, 885-890(1994)
113. S. Saika, S. Kono-Saika, Y. Ohnishi, M. Sato, Y. Muragaki, A. Ooshima, K. C. Flanders, J. Yoo, M. Anzano, C. Y. Liu, W. W. Kao, and A. B. Roberts: Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 164, 651-663(2004) (Pubitemid 38364679)
114. B. C. Willis, J. M. Liebler, K. Luby-Phelps, A. G. Nicholson, E. D. Crandall, R. M. du Bois, and Z. Borok: Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factorbeta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166, 1321-1332(2005) (Pubitemid 40586504)
115. H. Robertson, J. A. Kirby, W. W. Yip, D. E. Jones, and A. D. Burt: Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 45, 977-981(2007) (Pubitemid 46631566)
116. A. Kaimori, J. Potter, J. Y. Kaimori, C. Wang, E. Mezey, and A. Koteish: Transforming growth factorbeta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282, 22089-22101(2007) (Pubitemid 47195788)
117. K. C. Flanders: Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 85 4764 (2004)
118. R. Derynck, and Y. E. Zhang: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584(2003) (Pubitemid 37280136)
119. J. Zavadil, and E. P. Bottinger: TGF-and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774(2005)
120. Y. Li, J. Yang, C. Dai, C. Wu and Y. Liu: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112, 503-516(2003) (Pubitemid 38056335)
121. M. Sato, Y. Muragaki, S. Saika, A. B. Roberts, and A. Ooshima: Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112, 1486-1494(2003) (Pubitemid 38056275)
122. S. Saika, K. Ikeda, O. Yamanaka, M. Sato, Y. Muragaki, Y. Ohnishi, A. Ooshima, Y. Nakajima, K. Namikawa, H. Kiyama, K. C. Flanders, and A. B. Roberts: Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest 84, 1259-1270(2004) (Pubitemid 40063692)
123. S. Dooley, J. Hamzavi, L. Ciuclan, P. Godoy, I. Ilkavets, S. Ehnert, E. Ueberham, R. Gebhardt, S. Kanzler, A. Geier, K. Breitkopf, H. Weng, and P. R. Mertens: Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 135, 642-659(2008)
124. M Zeisberg, A. A. Shah, and R. Kalluri: Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 280, 8094-8100(2005) (Pubitemid 40349708)
125. M. Kowanetz, U. Valcourt, and R. Bergstrom: Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 24, 4241-4254(2004) (Pubitemid 41070996)
126. S. Wang, and R. Hirschberg: Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 279, 23200-23206(2004) (Pubitemid 38685626)
127. H. Benchabane, and J. L. Wrana: GATA-and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol Cell Biol 23, 6646-6661(2003) (Pubitemid 37075774)
128. O. A. Gressner, B. Lahme, I. Demirci, A. M. Gressner, and R. Weiskirchen: Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 47, 699-710(2007) (Pubitemid 47503426)
129. O. A. Gressner, B. Lahme, M. Siluschek, K. Rehbein, R. Weiskirchen, and A. M. Gressner: Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J Cell Mol Med, in press (2008)
130. H. L. Weng, L. Ciuclan, Y. Liu, J. Hamzavi, P. Godoy, H. Gaitantzi, S. Kanzler, R. Heuchel, U. Ueberham, R. Gebhardt, K. Breitkopf, and S. Dooley: Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 46, 1257-1270(2007) (Pubitemid 350144790)
131. D. M. Bradham, A. Igarashi, R. L. Potter, and G. R. Grotendorst: Connective tissue growth factor: a cysteinerich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114, 1285-1294(1991) (Pubitemid 21909886)
132. A. W. Rachfal, and D. R. Brigstock: Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 26, 1-9(2003) (Pubitemid 36939924)
133. A. Leask, and D. J. Abraham: All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119, 4803-4810(2006) (Pubitemid 46017793)
134. A. Leask, and D. J. Abraham: TGF-beta signaling and the fibrotic response. FASEB J 18, 816-827(2004)
135. G. R. Grotendorst, H. Okochi, and N. Hayashi: A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7, 469-480(1996) (Pubitemid 26362091)
136. P. Bork: The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327, 125-130(1993) (Pubitemid 23211174)
137. N. Hayashi, T. Kakimuma, Y. Soma, G. R. Grotendorst, K. Tamaki K, M. Harada M, and A. Igarashi: Connective tissue growth factor is directly related to liver fibrosis. Hepatogastroenterology 49, 133-135(2002) (Pubitemid 34289501)
138. V. Paradis, D. Dargere, M. Vidaud, A. C. de Gouville, S. Huet, V. Martinez, J. M. Gauthier, N. Ba, R. Sobesky, V. Ratziu, P. Bedossa: Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30, 968-976(1999) (Pubitemid 29458286)
139. J. George, and M. Tsutsumi: siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther 14, 790-803(2007) (Pubitemid 46706059)
140. G. Li, Q. Xie, Y. Shi, D. Li, M. Zhang, S. Jiang, H. Zhou, H. Lu, and Y. Jin: Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 8, 889-900(2006) (Pubitemid 44097143)
141. T. Q. Nguyen, P. Roestenberg, F. A. van Nieuwenhoven, N. Bovenschen, Z. Li, L. Xu, N. Oliver, J. Aten, J. A. Joles, C. Vial, E. Brandan, K. M. Lyons, and R. Goldschmeding: CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol, in press (2008)
142. J. G. Abreu, N. I. Ketpura, B. Reversade, and E. M. de Robertis: Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4, 599-604(2002)
143. O. A. Gressner, and A. M. Gressner: Connective tissue growth factor: A fibrogenic master switch in fibrotic liver diseases. Liver Int 28, 1065-1079(2008)
144. N. Kusu, J. Laurikkala, M. Imanishi, H. Usui, M. Konishi, A. Miyake, I. Thesleff, and N. Itoh: Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem 278, 24113-24117(2003) (Pubitemid 36830246)
145. M. Tanaka, S. Endo, T. Okuda, A. N. Economides, D. M. Valenzuela, A. J. Murphy, E. Robertson, T. Sakurai, A. Fukatsu, G. D. Yancopoulos, T. Kita, and M. Yanagita: Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury. Kidney Int 73, 181-191(2008)
146. J. Laurikkala, Y. Kassai, L. Pakkasjarvi, I. Thesleff, and N. Itoh: Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. Dev Biol 264, 91-105(2003) (Pubitemid 37393449)
147. J. Lin, S. R. Patel, M. Wang, and D. R. Dressler: The cysteine-rich domain protein KCP is a suppressor of transforming growth factor beta/activin signaling in renal epithelia. Mol Cell Biol 26, 4577-4585(2006) (Pubitemid 43877576)
148. A. M. Gressner, R. Weiskirchen, K. Breitkopf, and S. Dooley: Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: d793-d807 (2002)
149. Y. Murawaki, Y. Nishimura, Y. Ikuta, Y. Idobe, Y. Kitamura, and H. Kawasaki: Plasma transforming growth factor-beta1 concentrations in patients with chronic viral hepatitis. J Gastroenterol Hepatol 13, 680-684(1998) (Pubitemid 28407338)
150. F. Tacke, E. Gabele, F. Bataille, R. F. Schwabe, C. Hellerbrand, F. Klebl, R. H. Straub, T. Luedde, M. P. Manns, C. Trautwein, D. A. Brenner, J. Schölmerich, and B. Schnabl: Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci 52, 3404-3415(2007) (Pubitemid 350077191)
151. A. P. Hinck, S. J. Archer, S. W. Qian, A. B. Roberts, M. B. Sporn, J. A. Weatherbee, M. L. Tsang, R. Lucas, B. L. Zhang, J. Wenker, and D. A. Torchia: Transforming growth factor beta1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta2. Biochemistry 35, 8517-8534(1996) (Pubitemid 26240186)
152. G. P. Allendorph, M. J. Isaacs, Y. Kawakami, J. C. Belmonte, and S. Choe: BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. Biochemistry 46, 12238-12247(2007) (Pubitemid 350022378)
153. S. Saika, O. Yamanaka, T. Sumioka, T. Miyamoto, K. Miyazaki, Y. Okada, A. Kitano, K. Shirai, S. Tanaka, and K. Ikeda: Fibrotic disorders in the eye: Targets of gene therapy. Prog Retin Eye Res 27, 177-196(2008)